We can't find the internet
Attempting to reconnect
9949.1;5 PFLS-LS
Development of small molecule inhibitors of the respiratory syncytial virus polymerase complex.
Résumé
Development of small molecule inhibitors of the respiratory syncytial virus polymerase complex.
Textes supplémentaires
Abstract
Respiratory syncytial virus (RSV) is the principal cause of lower respiratory disease in infants and children necessitating 75,000 hospitalizations per year in the US alone. Despite its importance as a pathogen, there is neither a treatment nor a vaccine against RSV available. The project partners will develop novel, first-in-class antiviral drug candidates disrupting the interaction between two proteins of the RSV replicase complex, which is crucial for virus propagation.
Participants
Pius August Schubiger
Kontaktperson
august.schubiger@pharma.ethz.ch
ETH Zürich Pius August Schubiger Wolfgang-Pauli-Strasse 10 Institut für Pharmazeutische Wissen 8093 Zürich ZH CH
Détails du projet
- Office de recherche
- INNOSUISSE
- Statut du projet
- Abgeschlossen
- Type de projet
- Forschungsprojekt
- Date de début
- 2009-01-31
- Date de fin
- 2014-02-13
- Coûts totaux approuvés
- CHF 351051.00
- Section
- 20 Förderbereich Life Sciences
- Domaine politique NABS
- Nicht aufteilbare / nicht zuteilbare Forschung
Disciplines de recherche
- T115 Medical technology 100.0%